Pulmonary abscess secondary to epididymitis caused by extended spectrum β-lactamase-producing hypervirulent Klebsiella pneumoniae: a case report.
Klebsiella pneumonia
Klebsiella pneumonia invasion syndrome
Epididymitis
Extended-spectrum β-lactamase
Hypervirulence
Pulmonary abscess
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
13 Aug 2024
13 Aug 2024
Historique:
received:
09
01
2024
accepted:
05
08
2024
medline:
14
8
2024
pubmed:
14
8
2024
entrez:
13
8
2024
Statut:
epublish
Résumé
Pulmonary abscesses resulting from epididymitis caused by extended spectrum β-lactamase-producing hypervirulent Klebsiella pneumoniae (ESBL-hvKp) in a nondiabetic patient are extremely uncommon. The infection caused by this disseminated drug-resistant bacteria, which is generally considered an intractable case, poses a potential challenge in clinical practice. In this case report, we present the clinical course of a 71-year-old male patient with epididymitis, who subsequently developed cough and dyspnea following anti-infection treatment. Imaging examinations revealed severe pneumonia and pulmonary abscess. The infection of ESBL-hvKp in the epididymis led to bacteremia and subsequent lung lesions. Due to poor response to anti-infection therapy, the patient required an extended duration of anti-infection treatment and ultimately chosed to discontinue treatment. Acute epididymitis caused by ESBL-hvKP infection can result in the spread of the infection through the bloodstream, leading to severe pneumonia and lung abscess. Given the critical condition of the patient, even with active anti-infection treatment, there is a risk of treatment failure or potentially fatal outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
Pulmonary abscesses resulting from epididymitis caused by extended spectrum β-lactamase-producing hypervirulent Klebsiella pneumoniae (ESBL-hvKp) in a nondiabetic patient are extremely uncommon. The infection caused by this disseminated drug-resistant bacteria, which is generally considered an intractable case, poses a potential challenge in clinical practice.
CASE PRESENTATION
METHODS
In this case report, we present the clinical course of a 71-year-old male patient with epididymitis, who subsequently developed cough and dyspnea following anti-infection treatment. Imaging examinations revealed severe pneumonia and pulmonary abscess. The infection of ESBL-hvKp in the epididymis led to bacteremia and subsequent lung lesions. Due to poor response to anti-infection therapy, the patient required an extended duration of anti-infection treatment and ultimately chosed to discontinue treatment.
CONCLUSIONS
CONCLUSIONS
Acute epididymitis caused by ESBL-hvKP infection can result in the spread of the infection through the bloodstream, leading to severe pneumonia and lung abscess. Given the critical condition of the patient, even with active anti-infection treatment, there is a risk of treatment failure or potentially fatal outcomes.
Identifiants
pubmed: 39138429
doi: 10.1186/s12879-024-09721-2
pii: 10.1186/s12879-024-09721-2
doi:
Substances chimiques
beta-Lactamases
EC 3.5.2.6
Anti-Bacterial Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
820Informations de copyright
© 2024. The Author(s).
Références
Tan J, Tian M, Zhao F, Deng S, Jin P, Wang Y, Wen H, Qin X, Gong Y. An investigation of the male genitourinary abscess originated from urinary tract in a Tertiary Hospital, Shanghai, China, from 2004 to 2019. Infect Drug Resist. 2021;14:1795–803. https://doi.org/10.2147/IDR.S298250 . PMID: 34017185; PMCID: PMC8131006.
doi: 10.2147/IDR.S298250
pubmed: 34017185
pmcid: 8131006
Namikawa H, Yamada K, Fujimoto H, Oinuma KI, Tochino Y, Takemoto Y, Kaneko Y, Shuto T, Kakeya H. Two unusual cases of successful treatment of hypermucoviscous Klebsiella pneumoniae invasive syndrome. BMC Infect Dis. 2016;16(1):680. https://doi.org/10.1186/s12879-016-2011-3 . PMID: 27852233; PMCID: PMC5112683.
doi: 10.1186/s12879-016-2011-3
pubmed: 27852233
pmcid: 5112683
Sun R, Zhang H, Xu Y, Zhu H, Yu X, Xu J. Klebsiella pneumoniae-related invasive liver abscess syndrome complicated by purulent meningitis: a review of the literature and description of three cases. BMC Infect Dis. 2021;21(1):15. https://doi.org/10.1186/s12879-020-05702-3 . PMID: 33407192; PMCID: PMC7788956.
doi: 10.1186/s12879-020-05702-3
pubmed: 33407192
pmcid: 7788956
Lin YT, Cheng YH, Chuang C, Chou SH, Liu WH, Huang CH, Yang TC, Kreiswirth BN, Chen L. Molecular and clinical characterization of Multidrug-resistant and hypervirulent Klebsiella pneumoniae strains from Liver Abscess in Taiwan. Antimicrob Agents Chemother. 2020;64(5):e00174–20. https://doi.org/10.1128/AAC.00174-20 . PMID: 32152079; PMCID: PMC7179640.
doi: 10.1128/AAC.00174-20
pubmed: 32152079
pmcid: 7179640
Harada S, Aoki K, Yamamoto S, Ishii Y, Sekiya N, Kurai H, Furukawa K, Doi A, Tochitani K, Kubo K, Yamaguchi Y, Narita M, Kamiyama S, Suzuki J, Fukuchi T, Gu Y, Okinaka K, Shiiki S, Hayakawa K, Tachikawa N, Kasahara K, Nakamura T, Yokota K, Komatsu M, Takamiya M, Tateda K, Doi Y. Clinical and molecular characteristics of Klebsiella pneumoniae isolates Causing Bloodstream infections in Japan: occurrence of Hypervirulent infections in Health Care. J Clin Microbiol. 2019;57(11):e01206–19. https://doi.org/10.1128/JCM.01206-19 . PMID: 31434721; PMCID: PMC6812994.
doi: 10.1128/JCM.01206-19
pubmed: 31434721
pmcid: 6812994
Choby JE, Howard-Anderson J, Weiss DS. Hypervirulent Klebsiella pneumoniae - clinical and molecular perspectives. J Intern Med. 2020;287(3):283–300. https://doi.org/10.1111/joim.13007 . Epub 2019 Nov 21. PMID: 31677303; PMCID: PMC7057273.
doi: 10.1111/joim.13007
pubmed: 31677303
Martin RM, Bachman MA. Colonization, infection, and the Accessory Genome of Klebsiella pneumoniae. Front Cell Infect Microbiol. 2018;8:4. https://doi.org/10.3389/fcimb.2018.00004 . PMID: 29404282; PMCID: PMC5786545.
doi: 10.3389/fcimb.2018.00004
pubmed: 29404282
pmcid: 5786545
Zhang Y, Zhao C, Wang Q, Wang X, Chen H, Li H, Zhang F, Li S, Wang R, Wang H. High prevalence of Hypervirulent Klebsiella pneumoniae infection in China: Geographic distribution, clinical characteristics, and Antimicrobial Resistance. Antimicrob Agents Chemother. 2016;60(10):6115–20. https://doi.org/10.1128/AAC.01127-16 . PMID: 27480857; PMCID: PMC5038323.
doi: 10.1128/AAC.01127-16
pubmed: 27480857
pmcid: 5038323
Guo Y, Wang S, Zhan L, Jin Y, Duan J, Hao Z, Lv J, Qi X, Chen L, Kreiswirth BN, Wang L, Yu F. Microbiological and clinical characteristics of Hypermucoviscous Klebsiella pneumoniae isolates Associated with Invasive infections in China. Front Cell Infect Microbiol. 2017;7:24. https://doi.org/10.3389/fcimb.2017.00024 . PMID: 28203549; PMCID: PMC5286779.
doi: 10.3389/fcimb.2017.00024
pubmed: 28203549
pmcid: 5286779
Russo TA, Olson R, Macdonald U, Metzger D, Maltese LM, Drake EJ, Gulick AM. Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae. Infect Immun. 2014;82(6):2356–67. https://doi.org/10.1128/IAI.01667-13 . Epub 2014 Mar 24. PMID: 24664504; PMCID: PMC4019165.
doi: 10.1128/IAI.01667-13
pubmed: 24664504
pmcid: 4019165
Li G, Shi J, Zhao Y, Xie Y, Tang Y, Jiang X, Lu Y. Identification of hypervirulent Klebsiella pneumoniae isolates using the string test in combination with Galleria mellonella infectivity. Eur J Clin Microbiol Infect Dis. 2020;39(9):1673–9. https://doi.org/10.1007/s10096-020-03890-z . Epub 2020 Apr 21. PMID: 32318968.
doi: 10.1007/s10096-020-03890-z
pubmed: 32318968
Cheng FY, Su YJ. Septic Pulmonary Emboli Associated with Klebsiella Pneumoniae Epididymitis. J Emerg Med. 2016;50(1):e23–4. https://doi.org/10.1016/j.jemermed.2015.03.044 . Epub 2015 Oct 9. PMID: 26443643.
doi: 10.1016/j.jemermed.2015.03.044
pubmed: 26443643
Ojeda Gómez JSA, Carrillo Bayona JA, Morales Cifuentes LC. Septic pulmonary embolism secondary to Klebsiella pneumoniae Epididymitis: Case Report and Literature Review. Case Rep Radiol. 2019;2019:5395090. https://doi.org/10.1155/2019/5395090 . PMID: 31016062; PMCID: PMC6444252.
doi: 10.1155/2019/5395090
pubmed: 31016062
pmcid: 6444252
Li YM, Milikowski C, Selvaggi G, Abbo LM, Skiada D, Galimberti F. Polymyxin B-induced skin hyperpigmentation. Transpl Infect Dis. 2020;22(5):e13312. https://doi.org/10.1111/tid.13312 . Epub 2020 May 27. PMID: 32386075.
doi: 10.1111/tid.13312
pubmed: 32386075